ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Axulta, Kapseln
65402005 AstraZeneca AG
Axulta, Kapseln24.03.2015
  24.03.2015
Linaclotide (A06AX04) 
WHO-DDD 
 
04.08.11. 
B  
No 
IPCI
   
k.A. 
  
7680654020055Synthetika
  
Composition
Kapsel: linaclotidum 0.29 mg, cellulosum microcristallinum, hypromellosum, calcii chloridum dihydricum, leucinum, Kapselhülle: gelatina, E 171, E 172 (rubrum), E 172 (flavum), propylenglycolum, kalii hydroxidum, lacca, ammoniae solutio concentrata, E 172 (nigrum) pro capsula.
Packungsbestandteile
Capsules
 
Active AgentDoseadditional_information
Linaclotidum0.29 mgKapsel
 
Inactive agents additional_information
(Flavum)  
(Nigrum) pro Capsula  
(Rubrum)  
Ammoniae Solutio Concentrata  
Calcii Chloridum Dihydricum  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Gelatina Kapselhülle
Hypromellosum  
Kalii Hydroxidum  
Lacca  
Leucin  
Propylenglycol  
Source
Data was imported : 09.01.2026 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home